The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment. [electronic resource]
Producer: 20160425Description: 812-22 p. digitalISSN:- 1549-490X
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized -- immunology
- Antigens, CD -- immunology
- Antineoplastic Agents -- adverse effects
- CTLA-4 Antigen -- antagonists & inhibitors
- Humans
- Immunotherapy -- methods
- Ipilimumab
- Melanoma -- drug therapy
- Molecular Targeted Therapy
- Neoplasms -- drug therapy
- Programmed Cell Death 1 Receptor -- immunology
- T-Lymphocytes -- immunology
- Lymphocyte Activation Gene 3 Protein
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.